What is BioXcel Therapeutics, Inc. (BTAI)?
BioXcel Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapies that leverage artificial intelligence and data analytics to identify novel uses for existing drugs. The company concentrates on treatments in the fields of neuroscience and immunology, aiming to address unmet medical needs. BioXcel Therapeutics utilizes a platform approach to accelerate drug development by repurposing compounds with established safety profiles, potentially reducing development timelines and costs. The company engages in clinical research and collaborates with academic and industry partners to advance its pipeline of therapeutic candidates.
BioXcel Therapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by ongoing trades, with BioXcel Therapeutics, Inc. priced at $1.53. The intraday range has moved from $1.47 to $1.59, reflecting a daily change of 0%.
FAQ: BioXcel Therapeutics, Inc. (BTAI)
What is the current price of BTAI stock?
BioXcel Therapeutics, Inc. is currently valued at $1.53.
Does BTAI pay dividends?
BioXcel Therapeutics, Inc. does not pay dividends.
Does BTAI have a formal corporate presence or regional headquarters in the UAE?
BioXcel Therapeutics, Inc. does not have a regional office or subsidiary in the UAE and operates through partners.
What is BTAI best known for?
BioXcel Therapeutics, Inc. is most famous for its development of AI-enabled drug therapies.
What assets are typically shown together with BTAI?
Commonly shown alongside BTAI: Capricor Therapeutics Inc, Western Alliance Bancorp, LoanDepot Inc
Latest shares articles



